Masaaki Okabe
Niigata, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
Effect of Empagliflozin on Device-Measured Thoracic Impedance in Patients With Type 2 Diabetes Treated With an Implantable Cardioverter Defibrillator.
Journal: Circulation
Published: April 27, 2026
Direct Measurement of the In-Medium η^{'} Mass Spectrum through the γγ Decay Channel.
Journal: Physical review letters
Published: December 05, 2025
Sex Differences in Antiarrhythmic Effects of Empagliflozin: The EMPA-ICD Trial Subanalysis.
Journal: JACC. Asia
Published: September 01, 2025
Does Respiratory Sinus Arrhythmia Increase Nocturnal Blood Pressure?
Journal: International heart journal
Published: January 19, 2025
Effect of empagliflozin on ventricular arrhythmias in patients with type 2 diabetes treated with an implantable cardioverter-defibrillator: the EMPA-ICD trial.
Journal: Cardiovascular diabetology
Published: March 25, 2024
Is ischemic stimulus involved for J wave augmentation during coronary angiography and intracoronary administration of normal saline?
Journal: Pacing and clinical electrophysiology : PACE
Published: February 16, 2024
Incidence and Implications of J waves Observed During Coronary Angiography.
Journal: The American journal of cardiology
Published: July 12, 2021
J waves induced during coronary angiography in patients with vasospastic angina and its implication.
J waves induced during coronary angiography in patients with vasospastic angina and its implication.
Journal: Journal of electrocardiology
Published: November 06, 2020
Blood Pressure Increases Before Pulse Rate During the Nocturnal Period in Hypertensive Patients.
Journal: International heart journal
Published: May 19, 2020
Placebo-Controlled, Double-Blind Study of Empagliflozin (EMPA) and Implantable Cardioverter-Defibrillator (EMPA-ICD) in Patients with Type 2 Diabetes (T2DM): Rationale and Design.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: April 09, 2020
The Characteristics and Clinical Outcomes of Direct Oral Anticoagulantsin Patients with Atrial Fibrillation and Chronic Kidney Disease: From the Database of A Single-Center Registry.
Journal: Journal of atrial fibrillation
Published: April 04, 2020
Last Updated: 09/26/2026